• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

EMA’s policy on pharmacovigilance: access to qualitative data is needed, pharmacovigilance data are not “trade secrets”

September 15, 2014 Campaigns

Joint response to the EMA consultation by the Cochrane AEMG, HAI Europe, ISDB and MiEF. “Protection of personal data” must not be used as a pretext to strengthen intellectual property over pharmacovigilance data.

Attachment: 20140915jointresponseaccesspolicy.pdf

Recent Publications

  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021
  • ISDB Newsletter May 2021
  • ISDB Newsletter June 2020
  • Medicamentos y riesgo de neumonía [ES]

Newsletter

Recent Campaigns

  • Letter to Charles Michel on transparency in EU institutions
  • A letter to the Prime Minister of India
  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?
  • News from working groups: Clinical Trials Group

Contact

President
Dick Bijl
president @ isdbweb.org

Webmaster
Uw Computerstudent
toon.van.dort @ uwcomputerstudent.nl

Sign up to receive our newsletter.

Press releases

  • Statement: COVID-19 [EN]
  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)

Newsletters

  • ISDB Newsletter December 2021
  • ISDB Newsletter August 2021
  • ISDB Newsletter May 2021
  • ISDB Newsletter June 2020
  • Newsletter ISDB 2019 vol. 32 nr. 1, March 2019

© 2022 ISDB – International Society of Drug Bulletins.